Highlights Santen Pharmaceutical Co., Ltd.

Equities

4536

JP3336000009

Market Closed - Japan Exchange Other stock markets 11:30:00 15/05/2024 am IST			5-day change	1st Jan Change
1,607 ^JPY	-0.34%		+5.24%	+14.38%

10/05	Santen Pharmaceutical Intends to Buy Back and Cancel up to 38 Billion Yen Worth of Shares	MT
09/05	Santen Pharmaceutical Co., Ltd. announces an Equity Buyback for 21,110,000 shares, representing 5.81% for ¥38,000 million.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Santen Pharmaceutical Intends to Buy Back and Cancel up to 38 Billion Yen Worth of Shares	10/05	MT
Santen Pharmaceutical Co., Ltd. announces an Equity Buyback for 21,110,000 shares, representing 5.81% for ¥38,000 million.	09/05	CI
Santen Pharmaceutical Co., Ltd. Provides Year End Dividend Guidance for the Full Year Ending March 31, 2025	09/05	CI
Santen Pharmaceutical Co., Ltd. Announces Year End Dividend for the Year Ended March 31, 2024, Payable on June 26, 2024; Provides Dividend Guidance for the End of Second Quarter of 2025	09/05	CI
Santen Pharmaceutical Co., Ltd. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2025	09/05	CI
Santen Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	09/05	CI
Final dividend	28/03	FA
Santen Pharmaceutical to Cancel 12 Million Treasury Shares	26/03	MT
Tranche Update on Santen Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2023.	25/03	CI
Santen Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 11, 2023, has closed with 12,571,400 shares, representing 3.38% for ¥16,178.35 million.	22/03	CI
Santen Pharmaceutical's Returns to the Black in Fiscal Nine Months	09/02	MT
Santen Pharmaceutical Co., Ltd. Revises Dividend Guidance for the Fiscal Year Ending March 31, 2024	08/02	CI
Santen Pharmaceutical Further Repurchases Shares for Over 1 Billion Yen	08/01	MT
Tranche Update on Santen Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2023.	05/01	CI
Santen Pharmaceutical Buys Back Nearly 2 Billion Yen of Shares	04/12	MT
Santen Pharmaceutical’s Fiscal H1 EPS Increases to 69.68 Yen as Net Sales Rise 13.1% to 145.81 Billion Yen; Declares Interim Dividend of 16 Yen Per Share, Maintains Forecast	08/11	MT
Santen Pharmaceutical Co., Ltd. Revises Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2024	07/11	CI
Santen Pharmaceutical Co., Ltd. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on November 30, 2023; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	07/11	CI
Santen Pharmaceutical Buys Back 523,400 shares for 772.6 Million Yen in September	03/23/03	MT
Tranche Update on Santen Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2023.	02/23/02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Santen Pharmaceutical Co., Ltd.

Equities

4536

JP3336000009

Highlights

Filters